Last Updated: June 23, 2026

GALANTAMINE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Galantamine patents expire, and when can generic versions of Galantamine launch?

Galantamine is a drug marketed by Aurobindo Pharma, Barr, Impax Labs, Pharmobedient, Sun Pharm, Watson Labs, Hikma, Apotex Inc, Aurobindo Pharma Ltd, Chartwell Rx, Heritage Pharma, Mylan, Sandoz, Senores Pharms, Yabao Pharm, and Zydus Pharms Usa Inc. and is included in nineteen NDAs.

The generic ingredient in GALANTAMINE is galantamine hydrobromide. There are fifteen drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the galantamine hydrobromide profile page.

AI Deep Research
Questions you can ask:
  • What is the 5 year forecast for GALANTAMINE?
  • What are the global sales for GALANTAMINE?
  • What is Average Wholesale Price for GALANTAMINE?
Summary for GALANTAMINE
US Patents:0
Applicants:16
NDAs:19
Drug Prices: Drug price information for GALANTAMINE
DailyMed Link:GALANTAMINE at DailyMed

US Patents and Regulatory Information for GALANTAMINE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pharmobedient GALANTAMINE HYDROBROMIDE galantamine hydrobromide TABLET;ORAL 077603-001 Aug 28, 2008 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Heritage Pharma GALANTAMINE HYDROBROMIDE galantamine hydrobromide TABLET;ORAL 077585-001 Sep 15, 2009 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Senores Pharms GALANTAMINE HYDROBROMIDE galantamine hydrobromide TABLET;ORAL 077593-003 Sep 11, 2008 AB RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Sandoz GALANTAMINE HYDROBROMIDE galantamine hydrobromide TABLET;ORAL 077589-002 Jun 22, 2009 AB RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Yabao Pharm GALANTAMINE HYDROBROMIDE galantamine hydrobromide TABLET;ORAL 077604-001 Feb 6, 2009 AB RX No Yes ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.